Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Gilead Sciences, Inc.
Scientific Title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5745 Combined With mFOLFOX6 as First Line Treatment in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma